Podcast
Questions and Answers
What is a characteristic feature of Atopic Dermatitis (AD)?
What is a characteristic feature of Atopic Dermatitis (AD)?
What is the significance of filaggrin mutations in patients with Atopic Dermatitis?
What is the significance of filaggrin mutations in patients with Atopic Dermatitis?
Which immune responses are increased in patients with Atopic Dermatitis?
Which immune responses are increased in patients with Atopic Dermatitis?
How do genetic factors influence Atopic Dermatitis susceptibility?
How do genetic factors influence Atopic Dermatitis susceptibility?
Signup and view all the answers
What treatment approaches are commonly used for Atopic Dermatitis?
What treatment approaches are commonly used for Atopic Dermatitis?
Signup and view all the answers
What is primarily affected in patients with Netherton syndrome?
What is primarily affected in patients with Netherton syndrome?
Signup and view all the answers
What genetic mutation is associated with Job syndrome, known for hyper IgE levels?
What genetic mutation is associated with Job syndrome, known for hyper IgE levels?
Signup and view all the answers
Which treatment has shown effectiveness in managing atopic dermatitis (AD) by blocking IL-4 and IL-13 signaling?
Which treatment has shown effectiveness in managing atopic dermatitis (AD) by blocking IL-4 and IL-13 signaling?
Signup and view all the answers
What change in the skin microbiome is commonly observed during acute exacerbations of AD?
What change in the skin microbiome is commonly observed during acute exacerbations of AD?
Signup and view all the answers
Which of the following describes the role of JAK inhibitors in treating inflammatory diseases?
Which of the following describes the role of JAK inhibitors in treating inflammatory diseases?
Signup and view all the answers
Study Notes
Atopic Dermatitis (AD) Overview
- Atopic dermatitis (AD) is a common inflammatory skin disease.
- Characterized by dry, itchy skin and eczematous dermatitis.
- Often arises in childhood, sometimes accompanied by asthma, allergic rhinitis, and/or food allergies ("atopic march").
- Increased serum IgE and CCL17 (TARC) levels indicate a type 2 immune response.
- Multiple immune cell types (Th1, Th17, Th22) contribute to dermatitis.
- Commonly remits in late childhood, but can recur later.
- Current therapies include topical steroids, immunosuppressives, emollient creams, and antihistamines.
AD Pathogenesis & Genetics
- AD pathogenesis involves a combination of endogenous and exogenous factors.
- Loss-of-function mutations in the filaggrin gene are a causal factor.
- Genetic studies (GWAS) show that SNPs in multiple genes, including those involved in immune pathways (IL2, IL6R, IL7RA, IL18R1), are associated with AD.
- Genetic associations may overlap or differ depending on ethnicity.
- SNPs may not always directly correlate with functional changes or linked to different genes.
- Rare genetic diseases like Netherton syndrome (SPINK5 mutations) and Job syndrome (STAT3 mutations) offer mechanistic insights and potential links to AD.
AD & Microbiome
- Staphylococcus aureus (S. aureus) commonly colonizes AD skin.
- Increased abundance and frequency of S. aureus in AD skin microbiome, even during quiescent phases.
- Acute AD exacerbations correlate with S. aureus predominance in the skin microbiome.
- Mouse models show a relationship between disease activity, microbial dysbiosis, and S. aureus.
- Topical application of S. aureus causes eczema, while Corynebacterium species, a commensal microbe, does not. Corynebacterium may promote Th2 responses and IgE production.
- Microbial manipulation (e.g., bleach baths) as a potential AD therapy.
AD Treatment & Biologics
- Omalizumab, an anti-IgE antibody, is not effective for AD.
- This might suggest that AD inflammation isn't solely IgE-mediated.
- Dupilumab, which blocks IL-4 and IL-13 signaling, is effective in AD.
- IL-4 and IL-13 signaling pathways likely play roles in AD.
- Leukocyte sources of IL-4 and IL-13 (e.g., Th2 cells and innate lymphoid cells) need further study
- JAK inhibitors (e.g., tofacitinib) are also showing promise for topical AD treatment.
Summary - Additional Key Points
- Different genes influence AD susceptibility in different patient populations.
- Patch testing utility in AD is questionable, suggesting that contact allergens may not be the primary drivers of inflammation.
- AD is a multifactorial condition, with multiple genes and immune response pathways involved.
- Recent research suggests skin microbiome dysbiosis and inflammation could be key elements in a vicious cycle in AD.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
This quiz covers the essential aspects of atopic dermatitis (AD), including its clinical features and pathogenesis. Learn about the genetic factors influencing AD, the immune response involved, and current treatment options. Test your knowledge on this common inflammatory skin disease.
